A comparison of von Willebrand Factor antigen with platelet activity in vitro in normal and venous occlusion blood.
Von Willebrand Factor (vWF) is essential for normal haemostasis involving platelet aggregation induced by high shear forces. In vitro a functional test of platelet aggregation using the filterometer is abnormal in von Willebrand's disease. However in normal people there is no significant correlation between the antigenic assay of vWF and the filter results. To study this discrepancy normal blood before and during venous occlusion, and blood before and after infusion of 1 deamino-(8-D-arginine) vasopressin was studied. During venous occlusion (VO) the increase in vWF due to the release of large multimers correlated precisely with the increase in the filterometer results. That this was due to the plasma vWF and not to any change induced in the platelets was shown as follows: The methodology was altered so that a small amount of the donor's platelet-poor plasma (PPP) was added to homologous normal substrate blood. The effect of the added donor's PPP was then shown to be closely correlated to the increase in the antigenic assay. Analysis of vWF multimer size showed during VO an increase in large multimers. We conclude that the effect of vWF on normal blood may be obscured by variation in platelet aggregability. In the filterometer system as elsewhere the large active multimers probably play a major part in causing platelet adhesion, aggregation and filter blocking. The filterometer test is influenced by the amount of vWF antigen, by the molecular size and activity of the vWF and by platelet sensitivity. Clinically this is a useful global test.
O'Brien
J R
JR
Haematology Research, St Mary's Hospital, Portsmouth, UK.
Tsai
H M
HM
Etherington
M D
MD
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000941:Antigens / Q000502:physiology; D016022:Case-Control Studies; D003251:Constriction, Pathologic / Q000097:blood; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000494:pharmacology; D019281:Dimerization; D005260:Female; D005374:Filtration; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*; D010979:Platelet Function Tests; D013314:Stress, Mechanical; D014680:Veins / Q000473:pathology*; D014842:von Willebrand Diseases / Q000097:blood; D014841:von Willebrand Factor / Q000276:immunology* / Q000378:metabolism* / Q000494:pharmacology
D000941:Antigens; D014841:von Willebrand Factor; D003894:Deamino Arginine Vasopressin